13F filer · CIK 1510481 ↗
Sarasin & Partners LLP
You are looking at Q4 2024. See the latest, Q3 2026 →
Reported value
$9.06B
−14% on the quarter before
Positions
62
7 new · 25 sold out
Top 10
58.9%
of the value
Est. gain
+$173.5M
on stocks held all quarter
Est. return
+2.2%
on those stocks since Q3 2024
Positions as of Dec 31, 2024, from Sarasin & Partners LLP's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
Each tile is a position, sized by its share, colored by what the fund did with it since Q3 2024. Striped tiles are options.
Largest buys
Since Q3 2024, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Blackrock Inc~$264.7MNew · 0.0% → 2.9%+258,204 shares
- Microsoft~$209.1MAdded · 6.0% → 9.2%+496,086 shares
- Emerson Electric~$119.7MAdded · 0.8% → 2.4%+965,731 shares
- Ross Stores Inc~$86.7MNew · 0.0% → 1.0%+573,358 shares
- Kimberly-Clark Corp~$75.6MAdded · 0.6% → 1.4%+576,610 shares
- Meta~$66.4MAdded · 3.7% → 5.1%+113,433 shares
- Colgate Palmolive Co~$51.9MAdded · 2.9% → 3.5%+571,131 shares
- Alphabet~$31.7MAdded · 3.9% → 5.6%+167,609 shares
- Nvidia~$30.9MAdded · 4.9% → 6.7%+230,141 shares
- Graco Inc~$23.4MNew · 0.0% → 0.3%+278,161 shares
Largest sells
Since Q3 2024, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Zoetis Inc~$402.4MSold out · 3.8% → 0.0%−2,059,588 shares
- TSMC~$362.8MSold out · 3.4% → 0.0%−2,088,866 shares
- Unitedhealth Group Inc~$307.7MSold out · 2.9% → 0.0%−526,309 shares
- Thermo Fisher Scientific Inc~$302.1MSold out · 2.8% → 0.0%−488,325 shares
- Tetra Tech Inc New~$233.5MSold out · 2.2% → 0.0%−4,950,383 shares
- BlackRock~$224.3MSold out · 2.1% → 0.0%−236,243 shares
- Ishares Tr~$164.8MSold out · 1.6% → 0.0%−1,378,340 shares
- Deere & Co~$109.5MCut · 3.0% → 2.4%−258,522 shares
- Broadcom~$107.5MCut · 1.9% → 1.7%−463,736 shares
- Merck & Co Inc~$99.1MCut · 2.0% → 1.0%−995,784 shares
Holdings
As of Dec 31, 2024. Changes are in shares against Sep 30, 2024, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOM · shares +33% · price −2.0% | 9.2% | $833.5M | −$13.0M | ||||||||
| AppleCOM · shares −1.5% · price +7.5% | 7.6% | $692.0M | +$48.1M | ||||||||
| AmazonCOM · shares −9.1% · price +17.7% | 6.9% | $626.8M | +$94.5M | ||||||||
| NvidiaCOM · shares +5.3% · price +10.6% | 6.7% | $609.6M | +$55.4M | ||||||||
| AlphabetCAP STK CL A · shares +6.6% · price +14.1% | 5.6% | $509.3M | +$59.2M | ||||||||
| MetaCL A · shares +17% · price +2.3% | 5.1% | $466.2M | +$8.9M | ||||||||
| MastercardCL A · shares +4.8% · price +6.6% | 5.1% | $459.0M | +$27.3M | ||||||||
| Cme Group IncCOM · shares −1.1% · price +5.2% | 4.4% | $403.1M | +$20.1M | ||||||||
| Otis Worldwide CorpCOM · shares +6.0% · price −10.9% | 4.1% | $375.4M | −$43.3M | ||||||||
| Home Depot IncCOM · shares +2.7% · price −4.0% | 4.0% | $361.5M | −$14.7M | ||||||||
| Jpmorgan Chase & Co.COM · shares −16% · price +13.7% | 3.7% | $332.0M | +$40.0M | ||||||||
| Colgate Palmolive CoCOM · shares +19% · price −12.4% | 3.5% | $321.6M | −$38.3M | ||||||||
| Moody's CorporationCOM · shares −4.9% · price −0.3% | 2.9% | $266.2M | −$686,151 | ||||||||
| Blackrock IncCOM · shares New | 2.9% | $264.7M | — | ||||||||
| Costco Whsl Corp NewCOM · shares −7.9% · price +3.4% | 2.4% | $219.3M | +$7.1M | ||||||||
| Emerson ElectricCOM · shares +121% · price +13.3% | 2.4% | $218.9M | +$11.7M | ||||||||
| Deere & CoCOM · shares −33% · price +1.5% | 2.4% | $217.5M | +$3.3M | ||||||||
| Eli LillyCOM · shares +6.4% · price −12.9% | 2.2% | $197.2M | −$27.4M | ||||||||
| FortinetCOM · shares +1.1% · price +21.8% | 2.0% | $184.4M | +$32.7M | ||||||||
| American TowerCOM · shares +4.2% · price −21.1% | 1.9% | $171.7M | −$44.2M | ||||||||
| CiscoCOM · shares −8.2% · price +11.2% | 1.8% | $159.0M | +$16.1M | ||||||||
| BroadcomCOM · shares −40% · price +34.4% | 1.7% | $158.0M | +$40.4M | ||||||||
| Amgen IncCOM · shares −35% · price −19.1% | 1.5% | $138.7M | −$32.8M | ||||||||
| Kimberly-Clark CorpCOM · shares +140% · price −7.9% | 1.4% | $129.5M | −$4.6M | ||||||||
| MercadoLibreCOM · shares +1.0% · price −17.1% | 1.2% | $111.4M | −$22.8M | ||||||||
| Total · 62 positions | 100% | $9.06B | +$173.5M |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q3 2024 to Q4 2024: 55 stocks held throughout, up $173.5M (+2.2%).
- Amazon+$94.5M+18%
- Alphabet+$59.2M+14%
- Nvidia+$55.4M+11%
- Apple+$48.1M+7%
- Broadcom+$40.4M+34%
- Eli Lilly−$27.4M−13%
- Amgen Inc−$32.8M−19%
- Colgate Palmolive Co−$38.3M−12%
- Otis Worldwide Corp−$43.3M−11%
- American Tower−$44.2M−21%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q3 2026 | Oct 13, 2026 | $8.93B+5% | SEC ↗ |
| Q2 2026 | Jul 7, 2026 | $8.54B+4% | SEC ↗ |
| Q1 2026 | Apr 13, 2026 | $8.20B−15% | SEC ↗ |
| Q4 2025 | Jan 8, 2026 | $9.63B−5% | SEC ↗ |
| Q3 2025 | Oct 10, 2025 | $10.19B+1% | SEC ↗ |
| Q2 2025 | Jul 9, 2025 | $10.05B+9% | SEC ↗ |
| Q1 2025 | Apr 15, 2025 (amended) | $9.22B+2% | SEC ↗ |
| Q4 2024 | Jan 16, 2025 | $9.06B−14% | SEC ↗ |
| Q3 2024 | Oct 9, 2024 | $10.60B−6% | SEC ↗ |
| Q2 2024 | Jul 19, 2024 | $11.29B+11% | SEC ↗ |
| Q1 2024 | Apr 12, 2024 | $10.16B+12% | SEC ↗ |
| Q4 2023 | Jan 10, 2024 | $9.10B+14% | SEC ↗ |
| Q3 2023 | Oct 5, 2023 | $8.01B−7% | SEC ↗ |
| Q2 2023 | Jul 11, 2023 | $8.62B−54% | SEC ↗ |
| Q1 2023 | Apr 27, 2023 (amended) | $18.57B+143% | SEC ↗ |
| Q4 2022 | Jan 30, 2023 | $7.64B+6% | SEC ↗ |
| Q3 2022 | Oct 18, 2022 | $7.22B−9% | SEC ↗ |
| Q2 2022 | Jul 13, 2022 | $7.93B−20% | SEC ↗ |
| Q1 2022 | Apr 11, 2022 | $9.95B−9% | SEC ↗ |
| Q4 2021 | Jan 19, 2022 | $10.98B+11% | SEC ↗ |
| Q3 2021 | Oct 22, 2021 | $9.91B+3% | SEC ↗ |
| Q2 2021 | Jul 13, 2021 | $9.58B+13% | SEC ↗ |
| Q1 2021 | Apr 29, 2021 | $8.48B+12% | SEC ↗ |
| Q4 2020 | Jan 19, 2021 | $7.56B+9% | SEC ↗ |
| Q3 2020 | Nov 9, 2020 | $6.91B+11% | SEC ↗ |
| Q2 2020 | Jul 17, 2020 | $6.25B+23% | SEC ↗ |
| Q1 2020 | Apr 30, 2020 | $5.09B−22% | SEC ↗ |
| Q4 2019 | Feb 12, 2020 | $6.54B+8% | SEC ↗ |
| Q3 2019 | Nov 8, 2019 | $6.04B+6% | SEC ↗ |
| Q2 2019 | Jul 18, 2019 | $5.72B+10% | SEC ↗ |
| Q1 2019 | May 13, 2019 | $5.19B+13% | SEC ↗ |
| Q4 2018 | Feb 12, 2019 | $4.60B−13% | SEC ↗ |
| Q3 2018 | Nov 9, 2018 | $5.31B+4% | SEC ↗ |
| Q2 2018 | Aug 7, 2018 | $5.09B−0% | SEC ↗ |
| Q1 2018 | May 1, 2018 | $5.11B−1% | SEC ↗ |
| Q4 2017 | Feb 6, 2018 | $5.15B+4% | SEC ↗ |
| Q3 2017 | Nov 13, 2017 | $4.96B−3% | SEC ↗ |
| Q2 2017 | Aug 3, 2017 | $5.11B−1% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $5.14B−13% | SEC ↗ |
| Q4 2016 | Feb 10, 2017 | $5.91B−7% | SEC ↗ |
| Q3 2016 | Oct 14, 2016 | $6.38B+6% | SEC ↗ |
| Q2 2016 | Jul 14, 2016 | $6.02B−2% | SEC ↗ |
| Q1 2016 | Apr 27, 2016 | $6.13B | SEC ↗ |